Semoxin

Semoxin 400mg Tablet

Moxifloxacin

SEMOS PHARMACEUTICALS (PVT) LTD.

Drug Identity

Active Ingredient
Moxifloxacin
Chemical Class
Opiate
Pharmacological Group
on the basis of mechanism of action and also cl...
ATC Code
N02AE01, N07BC01
Status
Essential Medicine

What is Semoxin?

Uses
Buprenorphine (HCl) is a synthetic derivative of thebaine. Buprenorphine (HCl) is narcotic analgesic. Buprenorphine (HCl) is used to reli...

How It Works

Chemical Class
Opiate
Pharmacological Group
on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents and Analgesic-Narcotic pharmacological group

It is of Synthetic origin and belongs to Opiate. It belongs to Partial OPIATE agonist pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents and Analgesic-Narcotic pharmacological group. The Molecular Weight of Buprenorphine (HCl) is 504.00. Its pKa is 8.42, 9.92.

How to Take It

1
Adult · IV,IM
0.3 to 0.6 mg — 8 hourly
2
Adult · PO
0.4 to 0.2 mg — 8 hourly
3
Child · Intra Muscular
3 to 9 ug/kg — 8 hourly
-
4
Child · Intra Venous
3 to 9 ug/kg — 8 hourly
-

Safety Alerts

Buprenorphine (HCl) is contraindicated in conditions like Hypersensitivity, Pheochromocytoma, Respiratory disease, Paralytic ileus, Head injury, Atrophic oral candidiasis associated with dentures

Important Warnings

Buprenorphine should be used with caution and in low doses in patients with lungs, liver or kidney impairment, central nervous system (CNS) depression or patients undergoing biliary tract surgery
Patients should observe caution while driving or performing tasks requiring alertness, because it may cause drowsiness

Side Effects

The severe or irreversible adverse effects of Buprenorphine (HCl)which give rise to further complications include Hallucinations. Buprenorphine (HCl) produces potentially life-threatening effects which include Respiratory depression. which are responsible for the discontinuation of Buprenorphine (HCl) therapy. The symptomatic adverse reactions produced by Buprenorphine (HCl) are more or less tolerable and if they become severethey can be treated symptomaticallythese include DizzinessVertigoHeadacheNauseaVomitingConstipationSweatingInsomniaBack painAbdominal painAstheniaConstipation

Drug Interactions

Buprenorphine (HCl) is known to interact with other drugs
the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAlcoholAlfentanil (HCl)Naloxone (HCl)VORICONAZOLEVoriconazole may increase the serum concentration of buprenorphine by decreasing its metabolismMonitor for changes in the therapeutic and adverse effects of budesonide if voriconazole is initiated
discontinued or dose changed. These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Storage

Inj Store Below 40°C. Do not Freeze. Protect from Sunlight.

Price Intelligence

Rs 934.84
DRAP approved maximum price · per pack of 5 · approved 01 Sep, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 5Rs 934.84

Should you consider an alternative?

Other options containing Moxifloxacin, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.